. Author manuscript; available in PMC: 2016 Nov 1.

Published in final edited form as: Nutr Metab Cardiovasc Dis. 2015 Jul 29;25(11):1016–1024. doi: 10.1016/j.numecd.2015.07.006

Table 4.

The association between energy-adjusted n6 polyunsaturated fat intake and CVD- and all-cause mortality

Model^*	Quintiles of n6 fatty acid intake					P for trend
Model^*	1 (reference)	2	3	4	5	P for trend
CVD mortality
Statin users	1.00	0.65 (0.48, 0.89)	0.88 (0.65, 1.19)	0.77 (0.56, 1.07)	0.80 (0.57, 1.12)	0.48
Non-users	1.00	0.83 (0.70, 0.98)	0.74 (0.61, 0.90)	0.80 (0.65, 0.98)	0.72 (0.57, 0.93)	0.03
All-cause mortality
Statin users	1.00	0.92 (0.76, 1.11)	1.07 (0.88, 1.29)	1.00 (0.82, 1.22)	0.96 (0.78, 1.19)	0.90
Non-users	1.00	0.86 (0.78, 0.94)	0.82 (0.74, 0.91)	0.85 (0.75, 0.95)	0.80 (0.70, 0.92)	0.01

Values are reported as hazard ratios (95% confidence intervals) and are computed from a model that included sex, race, BMI, recruitment site, education, income, smoking, alcohol consumption, total energy, energy-adjusted n6-PUFA, saturated fat, monounsaturated fat and proteins, diabetes, statin use and the interaction between n6-PUFA and statin use.